Showing results (111-120 of 301) with videos related to

Sort By:
Pageof 31
Annals of Surgical Oncology|June 10, 2003
An experimental study on the pharmacokinetics of 5-fluorouracil regional chemotherapy for pancreatic cancerMasaaki Mitsutsuji, Yasuyuki Suzuki, Yasuhiro Iwanaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1995
[Retrospective analysis of postoperative chemotherapy with UFT against pancreatic cancer]O Ohashi, M Yamamoto, H Ishida, et al.
Case Reports in Gastrointestinal Medicine|January 24, 2020
Two Cases of Atraumatic Chylous Ascites Characterized by Hypotriglyceridemia and Partially Managed with an Oral Fat-Free Elemental DietMichihiro Kamigaki, Satoko Kunita, Makoto Nakano, et al.
Journal of Cardiovascular Pharmacology|March 18, 2005
Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertensionDaisuke Ikeda, Ichizo Tsujino, Hiroshi Ohira, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 20, 2009
[Assessment of chemotherapy-induced nausea and vomiting(CINV)using MASCC antiemesis tool]Mizuhiko Yamaguchi, Tomotaka Ogawa, Miyuki Watanabe, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1994
Development and characterization of chimeric anti-carcinoembryonic antigen monoclonal antibodies and their Fab fragmentsT Kamigaki, H Ohyanagi, M Yamamoto, et al.
Cytotherapy|September 14, 2010
Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumorsAtsutaka Noguchi, Toru Kaneko, Takashi Kamigaki, et al.
International Journal of Molecular Sciences|March 1, 2019
Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TRTakayuki Ueno, Norikazu Masuda, Shunji Kamigaki, et al.
Journal of Medical Case Reports|April 8, 2021
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reportsRishu Takimoto, Takashi Kamigaki, Takuji Gotoda, et al.
Oncotarget|February 9, 2018
Comprehensive immunotherapy combined with intratumoral injection of zoledronate-pulsed dendritic cells, intravenous adoptive activated T lymphocyte and gemcitabine in unresectable locally advanced pancreatic carcinoma: a phase I/II trialYoshiki Hirooka, Hiroki Kawashima, Eizaburo Ohno, et al.
Pageof 31